NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush

Journal of Neurotrauma

Volumn 14, Issue 9, 1997, Pages 665-675

  Yoles, Eti ^a   Muller, Shir ^a   Schwartz, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Neuroprotection glaucomatous neuropathy; NMDA receptors; Optic nerve lesion; White matter

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED VISUAL RESPONSE; GRAY MATTER; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVE CRUSH; NERVE DEGENERATION; NERVE FIBER; NERVE INJURY; NEUROPATHY; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; RAT; SPREADING CORTICAL DEPRESSION; WHITE MATTER;

EID: 0030866842     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1997.14.665     Document Type: Article

References (57)

1. AOKI, C., VENKATESAN, C., GO., C.G., MONG, J.A., and DAWSON, T.M. (1994). Cellular and subcellular localization of NMDA-R1 subunit immunoreactivity in the visual cortex of adult and neonatal rats. J. Neurosci. 14, 5202-5222.
2. ASCHER, P., and NOWAK, L. (1987). Electrophysiological studies of NMDA receptors. Trends Neurosci. 10, 284-328.
3. ASSIA, E., ROSNER, M., BELKIN, M., SOLOMON, A., and SCHWARTZ, M. (1989). Temporal parameters of low-energy laser irradiation for optimal delay of posttraumatic degeneration of rat optic nerve. Brain Res. 476, 205-212.
4. BAZAN, N.G., RODRIGUEZ DE TURCO, E.B., and ALLAN, G. (1995). Mediators of injury in neurotrauma: Intracellular signal transduction and gene expression. J. Neurotrauma 12, 791-814.
5. BERKELAAR, M., CLARKE, D.B., WANG, Y.C., BRAY, G.M., and AGUAYO, A.J. (1994). Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J. Neurosci. 14, 4368-4374.
6. BUCHAN, A., and PULSINELLI, W.A. (1990). Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J. Neurosci. 10, 311-316.
7. BULLOCK, R. (1995). Strategies neuroprotection with glutamate antagonists. Ann. N.Y. Acad. Sci. 765, 272-278.
8. BUYS, M., TROPE, E., and TATTON, W.G. (1992). (-)Deprenyl increases the survival of rat retinal ganglion cells after optic nerve crush. Curr. Eye Res. 14, 119-126.
9. DOBLE, A. (1995). Excitatory amino acid receptors and neurodegeneration. Therapie 50, 319-337.
10. DREYER, E.B., ZURAKOWSKI, D., SCHUMER, R.A., PODOS, S.M., and LIPTON, S.A. (1996). Elevated glutamate in the vitreous body of humans and monkeys with glaucoma. Arch. Opththalmol. 114, 299-305.
11. DUGAN, L.L., BRUNO, V.M., AMAGASU, S.M., and GIFFARD, R.G. (1995). Glia modulates the response of murine cortical neurons to excitotoxicity: Glia exacerbates AMPA neurotoxicity. J. Neurosci. 15, 4545-4555.
12. DUVDEVANI, R., ROSNER, M., BELKIN, M., SAUTTER, J., SABEL, B.A., and SCHWARTZ, M. (1990). Graded crush of the rat optic nerve as a brain injury model: Combining electrophysiological and behavioral outcome. Restor. Neurol. Neurosci. 2, 31-38.
13. EITAN, S., SOLOMON, A., LAVIE, V., YOLES, E., HIRSCHBERG, D.L., BELKIN, M., and SCHWARTZ, M. (1994). Recovery of visual response of injured adult rat optic nerves treated with transglutaminase. Science 264, 1764-1768.
14. FADEN, A.I. (1993). Experimental neurobiology of central nervous system trauma. Crit. Rev. Neurobiol. 7, 175-186.
15. FADEN, A.I. (1996a). Pharmacologic treatment of acute traumatic brain injury. JAMA 276, 569-570.
16. FADEN A.I. (1996b). Pharmacologic treatment of central nervous system trauma. Pharmacol. Toxicol. 78, 12-17.
17. FADEN, A.I., and SALZMAN, S. (1992). Pharmacological strategies in CNS trauma. Trends Pharmacol. Sci. 13, 29-35.
18. FADEN, A.I., LEMKE, M., SIMON, R.P., and NOBLE, L. J. (1988). N-methyl-D-aspartate antagonist MK-801 improves outcome following traumatic spinal cord injury in rats: Behavioral, anatomic and neurochemical studies. J. Neurotrauma 5, 33-45.
19. GEMBA, T., OSHIMA, T., and NINOMIYA, M. (1994). Glutamate efflux via the reversal of the sodium-dependent glutamate transporter caused by glycolytic inhibition in rat cultured astrocytes. Neuroscience 63, 789-795.
20. HERRERA, D.G., and CUELLO, A.C. (1992). MK-801 affects the potassium-induced increase of glial fibrillary acidic protein immunoreactivity in rat brain. Brain Res. 598, 286-293.
21. HOFFMAN, C.A., and BOAST, C.A. (1995). Neuroprotection by MK-801 in temperature maintained gerbils. Brain Res. Bull. 38, 405-409.
22. HUGHES, P., DRAGUNOW, M., BEILHARZ, E., LAWLOR, P., and GLUCKMAN, P. (1993). MK-801 induces immediate-early gene proteins and BDNF mRNA in rat cerebrocortical neurones. Neuroreport 4, 183-186.
23. JONES, K.A., and BAUGHMAN, R.W. (1991). Both NMDA and non-NMDA subtypes of glutamate receptors are concentrated at synapses on cerebral cortical neurons in culture. Neuron 7, 593-603.
24. KIMELBERG, H.K. (1992). Astrocytic edema in CNS trauma. J. Neurotrauma 9, 71-81.
25. KIMELBERG, H.K., RUTLEDGE, E., GODERIE, S., and CHARNIGA, C. (1995). Astrocytic swelling due to hypotonic or high K+ medium causes inhibition of glutamate and aspartate uptake and increases their release. J. Cereb. Blood Flow Metab. 15, 409-416.
26. LIU, D., and MCADOO, D.J. (1993). An experimental model combining microdialysis with electrophysiology, histology, and neurochemistry for exploring mechanisms of secondary damage in spinal cord injury: Effects of potassium. J. Neurotrauma 10, 349-362.
27. LIU, D., YANG, R., YAN, X., and MCADOO, D.J. (1994). Hydroxyl radicals generated in vivo kill neurons in the rat spinal cord: Electrophysiological, histological, and neurochemical results. J. Neurochem. 62, 37-44.
28. LYNCH, D.R., and DAWSON, T.M. (1994). Secondary mechanisms in neuronal trauma. Curr. Opin. Neurol. 7, 510-516.
29. MACDERMOTT, A.B., and DALE, N. (1987). Receptors, ion channels and synaptic potentials underlying the integrative actions of excitatory amino acids. Trends Neurosci. 10, 280-284.
30. MCINTOSH, T.K. (1993). Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: A review. J. Neurotrauma 10, 15-61.
31. MUIR, K.W., and LEES, K.R. (1995). Clinical experience with excitatory amino acid antagonist drugs. Stroke 26, 503-513.
32. NAKKI, R., KOISTINAHO, J., SHARP, F.R., and SAGAR, S.M. (1995). Cerebellar toxicity of phencyclidine. J. Neurosci. 15, 2097-2108.
33. PAN, Y., LO, E.H., MATSUMOTO, K., HAMBERG, L., and JIANG, H. (1995). Quantitative and dynamic MRI of neuroprotection in experimental stroke. J. Neurol. Sci. 131, 128-134.
34. PELLEGRINO, L.J., PELLEGRINO, A.S., and CUSHMAN, A.J. (1979). A stereotaxic atlas of the rat brain. Plenum Press, New York, 2nd ed.
35. POVLISHOCK, J.T., and CHRISTMAN, C.W. (1995). The pathobiology of traumatically induced axonal injury in animals and humans: A review of current thoughts. J. Neurotrauma 12, 555-564.
36. RANSOM, B.R., WAXMAN, S.G., and DAVIS, P.K. (1990). Anoxic injury of CNS white matter: Protective effect of ketamine. Neurology 40, 1399-1403.
37. SANNER, C.A., CUNNINGHAM, T.J., and GOLDBERGER, M.E. (1994). NMDA receptor blockade rescues Clarkeís and red nucleus neurons after spinal hemisection. J. Neurosci. 14, 6472-6480.
38. SAUTTER, J., SCHWARTZ, M., DUVDEVANI, R., and SABEL, B.A. (1991). GM1 ganglioside treatment reduces visual deficits after graded crush of the rat optic nerve. Brain Res. 565, 23-33.
39. SCHMITT, U., CROSS, R., PAZDERNIK, T.L., and SABEL, B.A. (1996). Loss and subsequent recovery of local cerebral glucose use in visual targets after controlled optic nerve crush in adult rats. Exp. Neurol. 139, 17-24.
40. SCHROETER, M., SCHIENE, K., KRAEMER, M., HAGEMANN, G., WEIGEL, H., EYSEL, U.T., WITTE, O.W., and STOLL, G. (1995). Astroglial responses in photochemically induced focal ischemia of the rat cortex. Exp. Brain Res. 106, 1-6.
41. SCHULZ, J.B., MATTHEWS, R.T., HENSHAW, D.R., and BEAL, M.F. (1996). Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: Implications for neurodegenerative diseases. Neuroscience 71, 1043-1048.
42. SCHUMER, R.A., and PODOS, S.M. (1994). The nerve of glaucoma. Arch. Ophthalmol. 112, 37-44.
43. SHAPIRA, Y., YADID, G., COTEV, S., NISKA A., and SHOHAMI, E. (1990). Protective effect of MK-801 in experimental brain injury. J. Neurotrauma. 7, 131-139.
44. SIEGEL, S.J., BROSE, N., JANSSEN, W.G., GASIC, G.P., JAHN, R., HEINEMANN, S.F., and MORRISON, J.H. (1994). Regional, cellular, and ultrastructural distribution of N-methyl-D-aspartate receptor subunit 1 in monkey hippocampus. Proc. Natl. Acad. Sci. U.S.A. 91, 564-568.
45. SMITH, D.H., CASEY, K., and MCINTOSH, T.K. (1995). Pharmacologic therapy for traumatic brain injury: Experimental approaches. New Horiz. 3, 562-572.
46. SOMBATI, S., COULTER, D.A., and DELORENZO, R.J. (1991). Neurotoxic activation of glutamate receptors induces an extended neuronal depolarization in cultured hippocampal neurons. Brain Res. 566, 316-319.
47. STAFSTROM, C.E., HOLMES, G.L., and THOMPSON, J.L. (1993). MK-801 pretreatment reduces kainic acid-induced spontaneous seizures in prepubescent rats. Epilepsy Res. 14, 41-48.
48. STEINPREIS, R.E., KRAMER, M.A., MIX, K.S., and PIWOWARCZYK, M.C. (1995). The effects of MK-801 on place conditioning. Neurosci. Res. 22, 427-430.
49. SUGIMOTO, A., TAKEDA, A., KOGURE, K., and ONODERA, H. (1994). NMDA receptor (NMDAR1) expression in the rat hippocampus after forebrain ischemia. Neurosci. Lett. 170, 39-42.
50. SWAN, J.H., and MELDRUM, B.S. (1990). Protection by NMDA antagonists against selective cell loss following transient ischaemia. J. Cereb. Blood Flow Metab. 10, 343-351.
51. SWANSON, R.A., FARRELL, K., and SIMON, R.P. (1995). Acidosis causes failure of atrocyte glutamate uptake during hypoxia. J. Cereb. Blood Flow Metab. 15, 417-424.
52. THANOS, S., MEY, J., and WILD, M. (1993). Treatment of adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J. Neurosci. 13, 455-466.
53. UEDA, Y., KATSUTA, K., NAKANISHI, H., and YOSHIDA, K. (1995). Noncompetitive NMDA antagonists, FR-115427 and MK-801, enhance neuronal survival in primary culture. Neurosci. Lett. 185, 107-110.
54. WONG, E.H., KEMP, J.A., PRIESTLEY, T., KNIGHT, A.R., WOODRUFF, G.N., and IVERSEN, L.L. (1986). The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. U.S.A. 83, 7104-7108.
55. YOLES, E., ZALISH, M., LAVIE, V., DUVDEVANI, R., BEN-BASSAT, S., and SCHWARTZ, M. (1992). GM1 reduces early injury-induced metabolic deficits and subsequent degeneration in the rat optic nerve. Invest. Ophthalmol. Vis. Sci. 83, 3586-3591.
56. YOLES, E., BELKIN, M., and SCHWARTZ, M. (1996). HU-211, a nonpsychotropic cannabinoid, produces short-and long-term neuroprotection after optic nerve axotomy. J. Neurotrauma 13, 49-57.
57. ZIVIN, J.A., and CHOI, D.W. (1991). Stroke therapy. Sci. Am. July, 36-43.